Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 4,086: | Line 4,086: | ||
| | | | ||
|- | |- | ||
} | |} | ||
==WHO Breast tumours (5th ed.) Content== | ==WHO Breast tumours (5th ed.) Content== | ||
{| class="wikitable" | {| class="wikitable" | ||
| Line 4,097: | Line 4,098: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
|-| | |-|Usual ductal hyperplasia||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,106: | Line 4,107: | ||
| | | | ||
|- | |- | ||
| | |Columnar cell lesions, including flat epithelial atypia ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,115: | Line 4,116: | ||
| | | | ||
|- | |- | ||
| | |Atypical ductal hyperplasia||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,124: | Line 4,125: | ||
| | | | ||
|- | |- | ||
| | |Sclerosing adenosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,133: | Line 4,134: | ||
| | | | ||
|- | |- | ||
| | |Apocrine adenosis and adenoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,142: | Line 4,143: | ||
| | | | ||
|- | |- | ||
| | |Microglandular adenosis ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,151: | Line 4,152: | ||
| | | | ||
|- | |- | ||
| | |Radial scar / complex sclerosing lesion ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,160: | Line 4,161: | ||
| | | | ||
|- | |- | ||
| | |Tubular adenoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,169: | Line 4,170: | ||
| | | | ||
|- | |- | ||
| | |Lactating adenoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,178: | Line 4,179: | ||
| | | | ||
|- | |- | ||
| | |Ductal adenoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,187: | Line 4,188: | ||
| | | | ||
|- | |- | ||
| | |Pleomorphic adenoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,196: | Line 4,197: | ||
| | | | ||
|- | |- | ||
| | |Adenomyoepithelioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,205: | Line 4,206: | ||
| | | | ||
|- | |- | ||
| | |Malignant adenomyoepithelioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,214: | Line 4,215: | ||
| | | | ||
|- | |- | ||
| | |Intraductal papilloma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,223: | Line 4,224: | ||
| | | | ||
|- | |- | ||
| | |Papillary ductal carcinoma in situ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,232: | Line 4,233: | ||
| | | | ||
|- | |- | ||
| | |Encapsulated papillary carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,241: | Line 4,242: | ||
| | | | ||
|- | |- | ||
| | |Solid papillary carcinoma (in situ and invasive)||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,250: | Line 4,251: | ||
| | | | ||
|- | |- | ||
| | |Invasive papillary carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,259: | Line 4,260: | ||
| | | | ||
|- | |- | ||
| | |Atypical lobular hyperplasia ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,268: | Line 4,269: | ||
| | | | ||
|- | |- | ||
| | |Lobular carcinoma in situ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,277: | Line 4,278: | ||
| | | | ||
|- | |- | ||
| | |Ductal carcinoma in situ ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,286: | Line 4,287: | ||
| | | | ||
|- | |- | ||
| | |Invasive breast carcinoma: General overview||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,295: | Line 4,296: | ||
| | | | ||
|- | |- | ||
| | |Invasive breast carcinoma of no special type||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,304: | Line 4,305: | ||
| | | | ||
|- | |- | ||
| | |Microinvasive carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,313: | Line 4,314: | ||
| | | | ||
|- | |- | ||
| | |Invasive lobular carcinoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,322: | Line 4,323: | ||
| | | | ||
|- | |- | ||
| | |Tubular carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,331: | Line 4,332: | ||
| | | | ||
|- | |- | ||
| | |Cribriform carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,340: | Line 4,341: | ||
| | | | ||
|- | |- | ||
| | |Mucinous carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,349: | Line 4,350: | ||
| | | | ||
|- | |- | ||
| | |Mucinous cystadenocarcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,358: | Line 4,359: | ||
| | | | ||
|- | |- | ||
| | |Invasive micropapillary carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,367: | Line 4,368: | ||
| | | | ||
|- | |- | ||
| | |Carcinoma with apocrine differentiation||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,376: | Line 4,377: | ||
| | | | ||
|- | |- | ||
| | |Metaplastic carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,385: | Line 4,386: | ||
| | | | ||
|- | |- | ||
| | |Acinic cell carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,394: | Line 4,395: | ||
| | | | ||
|- | |- | ||
| | |Adenoid cystic carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,403: | Line 4,404: | ||
| | | | ||
|- | |- | ||
| | |Secretory carcinoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,412: | Line 4,413: | ||
| | | | ||
|- | |- | ||
| | |Mucoepidermoid carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,421: | Line 4,422: | ||
| | | | ||
|- | |- | ||
| | |Polymorphous adenocarcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,430: | Line 4,431: | ||
| | | | ||
|- | |- | ||
| | |Tall cell carcinoma with reversed polarity||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,439: | Line 4,440: | ||
| | | | ||
|- | |- | ||
| | |Neuroendocrine tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,448: | Line 4,449: | ||
| | | | ||
|- | |- | ||
| | |Neuroendocrine carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,457: | Line 4,458: | ||
| | | | ||
|- | |- | ||
| | |Hamartoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,466: | Line 4,467: | ||
| | | | ||
|- | |- | ||
| | |Fibroadenoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,475: | Line 4,476: | ||
| | | | ||
|- | |- | ||
| | |Phyllodes tumour ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,484: | Line 4,485: | ||
| | | | ||
|- | |- | ||
| | |Syringomatous tumour ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,493: | Line 4,494: | ||
| | | | ||
|- | |- | ||
| | |Nipple adenoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,502: | Line 4,503: | ||
| | | | ||
|- | |- | ||
| | |Paget disease of the breast||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,511: | Line 4,512: | ||
| | | | ||
|- | |- | ||
| | |Haemangioma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,520: | Line 4,521: | ||
| | | | ||
|- | |- | ||
| | |Angiomatosis||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,529: | Line 4,530: | ||
| | | | ||
|- | |- | ||
| | |Atypical vascular lesions ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,538: | Line 4,539: | ||
| | | | ||
|- | |- | ||
| | |Postradiation angiosarcoma of the breast||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,547: | Line 4,548: | ||
| | | | ||
|- | |- | ||
| | |Primary angiosarcoma of the breast||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,556: | Line 4,557: | ||
| | | | ||
|- | |- | ||
| | |Nodular fasciitis||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,565: | Line 4,566: | ||
| | | | ||
|- | |- | ||
| | |Myofibroblastoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,574: | Line 4,575: | ||
| | | | ||
|- | |- | ||
| | |Desmoid fibromatosis ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,583: | Line 4,584: | ||
| | | | ||
|- | |- | ||
| | |Inflammatory myofibroblastic tumour ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,592: | Line 4,593: | ||
| | | | ||
|- | |- | ||
| | |Schwannoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,601: | Line 4,602: | ||
| | | | ||
|- | |- | ||
| | |Neurofibroma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,610: | Line 4,611: | ||
| | | | ||
|- | |- | ||
| | |Granular cell tumour||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,619: | Line 4,620: | ||
| | | | ||
|- | |- | ||
| | |Leiomyoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,628: | Line 4,629: | ||
| | | | ||
|- | |- | ||
| | |Leiomyosarcoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,637: | Line 4,638: | ||
| | | | ||
|- | |- | ||
| | |Lipoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,646: | Line 4,647: | ||
| | | | ||
|- | |- | ||
| | |Angiolipoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,655: | Line 4,656: | ||
| | | | ||
|- | |- | ||
| | |Liposarcoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,664: | Line 4,665: | ||
| | | | ||
|- | |- | ||
| | |Pseudoangiomatous stromal hyperplasia||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,673: | Line 4,674: | ||
| | | | ||
|- | |- | ||
| | |Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,682: | Line 4,683: | ||
| | | | ||
|- | |- | ||
| | |Follicular lymphoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,691: | Line 4,692: | ||
| | | | ||
|- | |- | ||
| | |Diffuse large B-cell lymphoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,700: | Line 4,701: | ||
| | | | ||
|- | |- | ||
| | |Burkitt lymphoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,709: | Line 4,710: | ||
| | | | ||
|- | |- | ||
| | |Breast implant-associated anaplastic large cell lymphoma ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,718: | Line 4,719: | ||
| | | | ||
|- | |- | ||
| | |Gynaecomastia||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,727: | Line 4,728: | ||
| | | | ||
|- | |- | ||
| | |Carcinoma in situ||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,736: | Line 4,737: | ||
| | | | ||
|- | |- | ||
| | |Invasive carcinoma||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,745: | Line 4,746: | ||
| | | | ||
|- | |- | ||
| | |Metastases to the breast||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,754: | Line 4,755: | ||
| | | | ||
|- | |- | ||
| | |BRCA1/2-associated hereditary breast and ovarian cancer syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,763: | Line 4,764: | ||
| | | | ||
|- | |- | ||
| | |Cowden syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,961: | Line 4,773: | ||
| | | | ||
|- | |- | ||
| | |Ataxia-telangiectasia||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,970: | Line 4,782: | ||
| | | | ||
|- | |- | ||
| | |Li-Fraumeni syndrome, TP53-associated||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,979: | Line 4,791: | ||
| | | | ||
|- | |- | ||
| | |Li-Fraumeni syndrome, CHEK2-associated||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,988: | Line 4,800: | ||
| | | | ||
|- | |- | ||
| | |CDH1-associated breast cancer||Disease|| | ||
| | | | ||
| | | | ||
| Line 4,997: | Line 4,809: | ||
| | | | ||
|- | |- | ||
| | |PALB2-associated cancers||Disease|| | ||
| | | | ||
| | | | ||
| Line 5,006: | Line 4,818: | ||
| | | | ||
|- | |- | ||
| | |Peutz-Jeghers syndrome||Disease|| | ||
| | | | ||
| | | | ||
| Line 5,024: | Line 4,836: | ||
| | | | ||
|- | |- | ||
| | |} | ||
} | |||
| | ||